Literature DB >> 19226560

Tissue engineering polymeric microcarriers with macroporous morphology and bone-bioactive surface.

Seok-Jung Hong1, Hye-Sun Yu, Hae-Won Kim.   

Abstract

PCL microspheres featuring a macroporous morphology and a bone-bioactive surface have been prepared. 'Camphene' was introduced to generate pores within the microsphere network. The pore size was variable from a few to tens to hundreds of microm depending on the Camphene/PCL ratio. Macropores (with sizes >50 microm) could be obtained with a Camphene/PCL ratio exceeding 6. The microsphere surface was further tailored with apatite mineral phase through solution-mediated precipitation, to endow the interface with bone bioactivity. Rat bone marrow stromal cells attached and spread actively on microspheres and populated well within their macropores. The developed microspheres may be potentially applicable as a cell delivery scaffold for bone tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226560     DOI: 10.1002/mabi.200800304

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  3 in total

1.  Performance of evacuated calcium phosphate microcarriers loaded with mesenchymal stem cells within a rat calvarium defect.

Authors:  Guang-Zhen Jin; Joong-Hyun Kim; Jeong-Hui Park; Seong-Jun Choi; Hae-Won Kim; Ivan Wall
Journal:  J Mater Sci Mater Med       Date:  2012-04-27       Impact factor: 3.896

2.  Utilizing PCL microcarriers for high-purity isolation of primary endothelial cells for tissue engineering.

Authors:  Guang-Zhen Jin; Jeong-Hui Park; Eun-Jung Lee; Ivan B Wall; Hae-Won Kim
Journal:  Tissue Eng Part C Methods       Date:  2014-06-16       Impact factor: 3.056

3.  Enhanced in vitro osteogenic differentiation of human fetal MSCs attached to 3D microcarriers versus harvested from 2D monolayers.

Authors:  Asha Shekaran; Eileen Sim; Kah Yong Tan; Jerry Kok Yen Chan; Mahesh Choolani; Shaul Reuveny; Steve Oh
Journal:  BMC Biotechnol       Date:  2015-10-31       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.